Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Alkermes plc - Ordinary Shares
(NQ:
ALKS
)
36.80
-0.15 (-0.41%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 22, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Alkermes plc - Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
The 3 Best Biotech Stocks to Invest in for Big Gains in 2024
↗
February 02, 2024
These pivotal biotech stocks for gains are charting the future of medicine and investment growth in 2024 offering powerful returns
Via
InvestorPlace
3 Top Pharma Stocks to Buy Now: February 2024
↗
February 01, 2024
Discover why these three pharma stocks should be on your buy list in February 2024 - they could be your ticket to explosive portfolio growth.
Via
InvestorPlace
For those who appreciate growth without the sticker shock, NASDAQ:ALKS is worth considering.
↗
February 01, 2024
Don't overlook ALKERMES PLC (NASDAQ:ALKS)—a stock with solid growth prospects and a reasonable valuation.
Via
Chartmill
Axsome Therapeutics Stock Showing Leadership, Earns 91 RS Rating
↗
January 23, 2024
Axsome Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
Via
Investor's Business Daily
Cassava Sciences Stock Continues Showing Rising Relative Strength
↗
January 16, 2024
Cassava Sciences sees its Relative Strength Rating move into the elite 90-plus level.
Via
Investor's Business Daily
The 3 Most Undervalued Biotech Stocks to Buy in January
↗
January 15, 2024
These are a number of undervalued biotech companies that investor should possibly look to add to their portfolios.
Via
InvestorPlace
NASDAQ:ALKS, a growth stock which is not overvalued.
↗
January 10, 2024
Investors seeking growth at a reasonable cost should explore NASDAQ:ALKS.
Via
Chartmill
Decoding 5 Analyst Evaluations For Alkermes
↗
January 02, 2024
Via
Benzinga
Delving into NASDAQ:ALKS's Growth Prospects.
↗
December 26, 2023
High growth, ROE and beating expectations for NASDAQ:ALKS: growth investors may appreciate this.
Via
Chartmill
Earnings Scheduled For February 15, 2024
↗
February 15, 2024
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.
Via
Benzinga
Alkermes's Earnings Outlook
↗
February 14, 2024
Via
Benzinga
CRISPR Therapeutics Stock Shows Rising Relative Strength, Hits 90+
↗
February 13, 2024
CRISPR Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
Via
Investor's Business Daily
NASDAQ:ALKS is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
↗
February 12, 2024
Investors should take notice ofALKERMES PLC (NASDAQ:ALKS)—it offers a great deal for the fundamentals it presents.
Via
Chartmill
7 Biotech Stocks Fighting America’s Deadliest Diseases
↗
February 08, 2024
Although the human condition can be alarmingly frail at times, these groundbreaking biotech stocks are aiming to right the ship.
Via
InvestorPlace
Is NASDAQ:ALKS suited for growth investing?
↗
February 07, 2024
Why the growth investor may take a look at NASDAQ:ALKS.
Via
Chartmill
Madrigal Pharmaceuticals Stock Shows Rising Relative Strength
↗
February 06, 2024
A Relative Strength Rating upgrade for Madrigal Pharmaceuticals shows improving technical performance.
Via
Investor's Business Daily
NASDAQ:ALKS, an undervalued stock with good fundamentals.
↗
January 19, 2024
Investors should take notice ofALKERMES PLC (NASDAQ:ALKS)—it offers a great deal for the fundamentals it presents.
Via
Chartmill
Why the growth investor may take a look at ALKERMES PLC (NASDAQ:ALKS).
↗
January 16, 2024
High growth, ROE and beating expectations for NASDAQ:ALKS: growth investors may appreciate this.
Via
Chartmill
ALKERMES PLC (NASDAQ:ALKS) showing high EPS and FCF growth while beating expectations
↗
December 04, 2023
Why the growth investor may take a look at NASDAQ:ALKS.
Via
Chartmill
For those who appreciate value investing, NASDAQ:ALKS is a compelling option with its solid fundamentals.
↗
December 28, 2023
Investors should take notice ofALKERMES PLC (NASDAQ:ALKS)—it offers a great deal for the fundamentals it presents.
Via
Chartmill
For those who appreciate growth without the sticker shock, NASDAQ:ALKS is worth considering.
↗
December 20, 2023
Looking for growth without the hefty price tag? Consider ALKERMES PLC (NASDAQ:ALKS).
Via
Chartmill
When you look at NASDAQ:ALKS, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
↗
December 07, 2023
ALKERMES PLC (NASDAQ:ALKS) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via
Chartmill
Uber Will Join The S&P 500 Index. The Stock Is Jumping.
↗
December 01, 2023
The ride-hailing giant will join the index as part of a quarterly rebalancing.
Via
Investor's Business Daily
Topics
Stocks
For those who appreciate growth without the sticker shock, NASDAQ:ALKS is worth considering.
↗
November 29, 2023
Investors seeking growth at a reasonable cost should explore NASDAQ:ALKS.
Via
Chartmill
Where Alkermes Stands With Analysts
↗
November 20, 2023
Via
Benzinga
NASDAQ:ALKS: good value for what you're paying.
↗
November 16, 2023
Investors should take notice ofALKERMES PLC (NASDAQ:ALKS)—it offers a great deal for the fundamentals it presents.
Via
Chartmill
NASDAQ:ALKS—A High-Growth Stock Gearing Up for Its Next Upward Move.
↗
November 14, 2023
Is ALKERMES PLC (NASDAQ:ALKS) on the Verge of a Major Breakout as a Strong Growth Stock?
Via
Chartmill
Why Is Mural Oncology (MURA) Stock Up 59% Today?
↗
November 17, 2023
Mural Oncology stock is climbing higher on Friday as the company's shares bounce back from a dip yesterday during its public debut.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
November 17, 2023
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
3 Growth Stocks Set to Dominate the Decade
↗
November 14, 2023
Here are three growth stocks to buy that are poised to dominate the decade. Add them to your portfolio for long-term financial success.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
